Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zogenix Begins Promotion of Migranal Nasal Spray
Yahoo/GlobeNewsWire
Thursday, August 1, 2013 - 9:11am
tags:
Zogenix, Migranal, migraines
J&J Fined in China as Eli Lilly, Sanofi Visited by Regulators
Bloomberg
Thursday, August 1, 2013 - 9:10am
tags:
JNJ, Eli Lilly, Sanofi
Revenue, Earnings And Profits All Fall At AstraZeneca Plc
Motley Fool
Thursday, August 1, 2013 - 8:50am
tags:
AstraZeneca, earnings
Sanofi Q2 2013 - Interview with CEO Chris Viehbacher
Euro Business media
Thursday, August 1, 2013 - 8:48am
tags:
Sanofi, earnings
Arena Pharmaceuticals, Inc. Management Discusses Q2 2013 Results (Webcast)
Seeking Alpha
Thursday, August 1, 2013 - 8:47am
tags:
Arena Pharmaceuticals, earnings
BrainStorm Submits Favorable Interim Safety Report for Second Group of Patients in Its Phase IIa Dose-Escalating Trial of NurOwn in ALS
Yahoo/MarketWire
Thursday, August 1, 2013 - 8:44am
tags:
BrainStorm Cell Therapeutics, Lou Gehrig's disease, ALS, stem cells, NurOwn
MorphoSys Plans to Raise Spending on Immunotherapy Treatments
Bloomberg
Thursday, August 1, 2013 - 8:42am
tags:
MorphoSys, immunotherapy
NPS Pharmaceuticals Enrolls First Patient in Global Registry Designed to Characterize the Natural History of Hypoparathyroidism
Yahoo/BusinessWire
Thursday, August 1, 2013 - 8:41am
tags:
NPS Pharmaceuticals, hypoparathyroidism
US Army Selects Premier Biomedical, Inc. for Cure for Traumatic Brain Injury, Clinical Depression, and Suicide Ideation; Joint Press Conference with Video
Yahoo/AccessWire
Thursday, August 1, 2013 - 8:40am
tags:
Premier Biomedical
Optimer Reports Second Quarter 2013 Financial Results
Yahoo/PR Newswire
Thursday, August 1, 2013 - 8:38am
tags:
Optimer Pharmaceuticals, earnings
Discounted Price Levels Make CEL-SCI Shares a Solid Speculative "Buy" Bet
Yahoo/MarketWire
Thursday, August 1, 2013 - 8:37am
tags:
Cel-Sci
Industry Funding For Continuing Medical Education Declines Again
Pharmalot
Wednesday, July 31, 2013 - 7:01pm
tags:
physicians, CME
Idenix Pharmaceuticals: Potential Multi-Bagger Means Little Risk/High Reward
Seeking Alpha
Wednesday, July 31, 2013 - 10:13am
tags:
Idenix
OncoGenex to Webcast Discussion of Clinical Development Program and Second Quarter 2013 Financial Results on August 8, 2013
MarketWatch
Wednesday, July 31, 2013 - 10:08am
tags:
OncoGenex, earnings
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
Wall Street Journal
Wednesday, July 31, 2013 - 10:07am
tags:
Alexza Pharmaceuticals, agitation, Adasuve
Rhythm Pharmaceuticals lands $11M tranche to advance its treatment of GI disorders
bizjournals
Wednesday, July 31, 2013 - 10:05am
tags:
Rhythm Pharmaceuticals, gastroparesis, diabetes, obesity
Allergan Reports Second Quarter 2013 Operating Results
Yahoo/BusinessWire
Wednesday, July 31, 2013 - 9:55am
tags:
Allergan, earnings
SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Trius Therapeutics, Inc. in Connection with the Sale of Company to Cubist Pharmaceuticals, Inc.
Yahoo/BusinessWire
Wednesday, July 31, 2013 - 9:54am
tags:
Cubist Pharmaceuticals, Trius Therapeutics, M&A, lawsuits
Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals
Yahoo/BusinessWire
Wednesday, July 31, 2013 - 9:53am
tags:
Cubist Pharmaceuticals, Optimer Pharmaceuticals, M&A
Cubist Pharmaceuticals to Acquire Trius Therapeutics
Yahoo/BusinessWire
Wednesday, July 31, 2013 - 9:51am
tags:
Cubist Pharmaceuticals, Trius Therapeutics, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.